NDC product
Xpect Pain Away Extra Strength
NDC 42961-234 · Cintas Corporation
Key facts
| Product NDC | 42961-234 |
|---|---|
| Proprietary name | Xpect Pain Away Extra Strength |
| Nonproprietary name | Acetaminophen Aspirin Caffeine |
| Substances | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | Cintas Corporation |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M013 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE] and 5 more |
| Marketing start | Jul 26, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: